Cargando…

Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma

Genotoxic cancer therapies, such as chemoradiation, cause haematological toxicity primarily by activating the tumour suppressor p53. While inhibiting p53-mediated cell death during cancer therapy ameliorates haematologic toxicity, whether it also impacts carcinogenesis remains unclear. Here we utili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chang-Lung, Castle, Katherine D., Moding, Everett J., Blum, Jordan M., Williams, Nerissa, Luo, Lixia, Ma, Yan, Borst, Luke B., Kim, Yongbaek, Kirsch, David G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586051/ https://www.ncbi.nlm.nih.gov/pubmed/26399548 http://dx.doi.org/10.1038/ncomms9477

Ejemplares similares

Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice
por: Lee, Chang-Lung, et al.
Publicado: (2012)

The tumour suppressor CYLD regulates the p53 DNA damage response
por: Fernández-Majada, Vanesa, et al.
Publicado: (2016)

Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993)

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
por: Shi, Y. F., et al.
Publicado: (1996)

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
por: Barton, C. M., et al.
Publicado: (1991)

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer
Publicado: (1992)

Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
por: Haupt, Sue, et al.
Publicado: (2021)

Regulation of the DNA Damage Response and Gene Expression by the Dot1L Histone Methyltransferase and the 53Bp1 Tumour Suppressor
por: FitzGerald, Jennifer, et al.
Publicado: (2011)

Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors
por: Moding, Everett J., et al.
Publicado: (2017)

Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA
por: Veprintsev, Dmitry B., et al.
Publicado: (2008)

Variable expressivity of the tumour suppressor protein TRP53 in cryopreserved human blastocysts
por: Chandrakanthan, Vashe, et al.
Publicado: (2007)

Effects of CpG Methylation on Recognition of DNA by the Tumour Suppressor p53
por: Petrovich, Miriana, et al.
Publicado: (2009)

Quantitative model for inferring dynamic regulation of the tumour suppressor gene p53
por: Wang, Junbai, et al.
Publicado: (2010)

Structure and Stability Insights into Tumour Suppressor p53 Evolutionary Related Proteins
por: Pagano, Bruno, et al.
Publicado: (2013)

Discussion of some ‘knowns’ and some ‘unknowns’ about the tumour suppressor p53
por: Lieschke, Elizabeth, et al.
Publicado: (2018)

Liquid Biopsies for Molecular Biology-Based Radiotherapy
por: Blomain, Erik S., et al.
Publicado: (2021)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.
por: Cook, A., et al.
Publicado: (1990)

Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges.
por: Birch, J. M.
Publicado: (1992)

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.
por: Levine, A. J., et al.
Publicado: (1994)

The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.
por: Joypaul, B. V., et al.
Publicado: (1994)

TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
por: Mastropasqua, Francesca, et al.
Publicado: (2017)

Interleukin-1α associates with the tumor suppressor p53 following DNA damage
por: Novak, J., et al.
Publicado: (2020)

Analysis of the DNA Binding Activity of BRCA1 and Its Modulation by the Tumour Suppressor p53
por: Naseem, Riffat, et al.
Publicado: (2008)

The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.
por: Meling, G. I., et al.
Publicado: (1993)

Shaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures
por: Karakostis, Konstantinos, et al.
Publicado: (2019)

Tumor Suppressor P53 Binding Protein 1 (53bp1) Is Involved in DNA Damage–Signaling Pathways
por: Rappold, Irene, et al.
Publicado: (2001)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Progress in the research of p53 tumour suppressor activity controlled by Numb in triple‐negative breast cancer
por: Xian, Jie, et al.
Publicado: (2020)

A Reliable BioFET Immunosensor for Detection of p53 Tumour Suppressor in Physiological-Like Environment
por: Baldacchini, Chiara, et al.
Publicado: (2020)

Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer
por: Alhebshi, Hasen, et al.
Publicado: (2021)

Assessing the Radiation Response of Lung Cancer with Different Gene Mutations Using Genetically Engineered Mice
por: Perez, Bradford A., et al.
Publicado: (2013)

Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene TP53 Using Human TP53 Knock-in (Hupki) Mouse Embryo Fibroblasts
por: Hölzl-Armstrong, Lisa, et al.
Publicado: (2019)

Tumor suppressor p53 and metabolism
por: Liu, Juan, et al.
Publicado: (2018)

Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas
por: Daniel, Andrea R., et al.
Publicado: (2023)

Dual-Energy Micro-CT Functional Imaging of Primary Lung Cancer in Mice Using Gold and Iodine Nanoparticle Contrast Agents: A Validation Study
por: Ashton, Jeffrey R., et al.
Publicado: (2014)

Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes
por: Mühlbauer, K-R, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_1o5kkfep332tbm7j8bpnjj66rq